Literature DB >> 10770555

The development of lipodystrophy on a protease inhibitor-sparing highly active antiretroviral therapy regimen.

G Leitz, P Robinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10770555     DOI： 10.1097/00002030-200003100-00026

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

Review 1.  Endocrinological aspects of HIV infection.

Authors:  F S Mirza; P Luthra; L Chirch
Journal:  J Endocrinol Invest       Date:  2018-01-08       Impact factor: 4.256

2.  Nevirapine plus efavirenz plus didanosine: a simple, safe, and effective once-daily regimen for patients with HIV infection.

Authors:  Wilbert C Jordan; Ronald Jefferson; Francis Yemofio; Laurie Tolbert; Vivian Conlon; Harlon Carroll; D Christopher Green; Aaron Green; Rachel Green
Journal:  J Natl Med Assoc       Date:  2003-12       Impact factor: 1.798

3.  New and emerging agents in the management of lipodystrophy in HIV-infected patients.

Authors:  Eric Bonnet
Journal:  HIV AIDS (Auckl)       Date:  2010-09-17

Review 4.  HIV-associated lipodystrophy: a review from a Brazilian perspective.

Authors:  Marcelle D Alves; Carlos Brites; Eduardo Sprinz
Journal:  Ther Clin Risk Manag       Date:  2014-07-17       Impact factor: 2.423
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.